Author Correction: Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
Wen Juan Tu(QIMR Berghofer Medical Research Institute), Sudha Rao(QIMR Berghofer Medical Research Institute), Daniel J. Rawle(QIMR Berghofer Medical Research Institute), Michelle Melino(QIMR Berghofer Medical Research Institute), Kexin Yan(QIMR Berghofer Medical Research Institute), Jade K. Forwood(Charles Sturt University), Natasha Collinson(QIMR Berghofer Medical Research Institute), Elizabeth Ahern(Monash Health), Nicola Waddell(QIMR Berghofer Medical Research Institute), Andreas Suhrbier(The University of Queensland), Robert McCuaig(University of Canberra), Lambros T. Koufariotis(QIMR Berghofer Medical Research Institute), Amanda L. Bain(Griffith University), E.M. Cross(Charles Sturt University), Simon Phipps(Queensland University of Technology), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Thuy T. Le(The University of Melbourne), S. Tsimbalyuk(Charles Sturt University), Nabila Seddiki(Inserm)
Cited by 1
Related Papers
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
Genome-wide analysis of long noncoding RNA stability
|Genome Research|2012|592
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
|Brain Behavior and Immunity|2009|574